BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25132238)

  • 1. The cistrome and gene signature of androgen receptor splice variants in castration resistant prostate cancer cells.
    Lu J; Lonergan PE; Nacusi LP; Wang L; Schmidt LJ; Sun Z; Van der Steen T; Boorjian SA; Kosari F; Vasmatzis G; Klee GG; Balk SP; Huang H; Wang C; Tindall DJ
    J Urol; 2015 Feb; 193(2):690-8. PubMed ID: 25132238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen receptor splice variants bind to constitutively open chromatin and promote abiraterone-resistant growth of prostate cancer.
    He Y; Lu J; Ye Z; Hao S; Wang L; Kohli M; Tindall DJ; Li B; Zhu R; Wang L; Huang H
    Nucleic Acids Res; 2018 Feb; 46(4):1895-1911. PubMed ID: 29309643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor.
    Watson PA; Chen YF; Balbas MD; Wongvipat J; Socci ND; Viale A; Kim K; Sawyers CL
    Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16759-65. PubMed ID: 20823238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor splice variant 7 in castration-resistant prostate cancer: Clinical considerations.
    Bryce AH; Antonarakis ES
    Int J Urol; 2016 Aug; 23(8):646-53. PubMed ID: 27255944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging data on androgen receptor splice variants in prostate cancer.
    Cao S; Zhan Y; Dong Y
    Endocr Relat Cancer; 2016 Dec; 23(12):T199-T210. PubMed ID: 27702752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation 2.5 antisense oligonucleotides targeting the androgen receptor and its splice variants suppress enzalutamide-resistant prostate cancer cell growth.
    Yamamoto Y; Loriot Y; Beraldi E; Zhang F; Wyatt AW; Al Nakouzi N; Mo F; Zhou T; Kim Y; Monia BP; MacLeod AR; Fazli L; Wang Y; Collins CC; Zoubeidi A; Gleave M
    Clin Cancer Res; 2015 Apr; 21(7):1675-87. PubMed ID: 25634993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Profiling of the Androgen Receptor in Liquid Biopsies from Castration-resistant Prostate Cancer Reveals Novel Intra-AR Structural Variation and Splice Variant Expression Patterns.
    De Laere B; van Dam PJ; Whitington T; Mayrhofer M; Diaz EH; Van den Eynden G; Vandebroek J; Del-Favero J; Van Laere S; Dirix L; Grönberg H; Lindberg J
    Eur Urol; 2017 Aug; 72(2):192-200. PubMed ID: 28104311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model.
    Nakata D; Nakayama K; Masaki T; Tanaka A; Kusaka M; Watanabe T
    Prostate; 2016 Dec; 76(16):1536-1545. PubMed ID: 27473672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer.
    Cato L; de Tribolet-Hardy J; Lee I; Rottenberg JT; Coleman I; Melchers D; Houtman R; Xiao T; Li W; Uo T; Sun S; Kuznik NC; Göppert B; Ozgun F; van Royen ME; Houtsmuller AB; Vadhi R; Rao PK; Li L; Balk SP; Den RB; Trock BJ; Karnes RJ; Jenkins RB; Klein EA; Davicioni E; Gruhl FJ; Long HW; Liu XS; Cato ACB; Lack NA; Nelson PS; Plymate SR; Groner AC; Brown M
    Cancer Cell; 2019 Mar; 35(3):401-413.e6. PubMed ID: 30773341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minnelide Inhibits Androgen Dependent, Castration Resistant Prostate Cancer Growth by Decreasing Expression of Androgen Receptor Full Length and Splice Variants.
    Isharwal S; Modi S; Arora N; Uhlrich C; Giri B; Barlass U; Soubra A; Chugh R; Dehm SM; Dudeja V; Saluja A; Banerjee S; Konety B
    Prostate; 2017 May; 77(6):584-596. PubMed ID: 28144973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Marked response to cabazitaxel in prostate cancer xenografts expressing androgen receptor variant 7 and reversion of acquired resistance by anti-androgens.
    Ylitalo EB; Thysell E; Thellenberg-Karlsson C; Lundholm M; Widmark A; Bergh A; Josefsson A; Brattsand M; Wikström P
    Prostate; 2020 Feb; 80(2):214-224. PubMed ID: 31799745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.
    Sun S; Sprenger CC; Vessella RL; Haugk K; Soriano K; Mostaghel EA; Page ST; Coleman IM; Nguyen HM; Sun H; Nelson PS; Plymate SR
    J Clin Invest; 2010 Aug; 120(8):2715-30. PubMed ID: 20644256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raddeanin A down-regulates androgen receptor and its splice variants in prostate cancer.
    Xia H; Hu C; Bai S; Lyu J; Zhang BY; Yu X; Zhan Y; Zhao L; Dong Y
    J Cell Mol Med; 2019 May; 23(5):3656-3664. PubMed ID: 30905075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival.
    Peacock SO; Fahrenholtz CD; Burnstein KL
    Mol Endocrinol; 2012 Dec; 26(12):1967-79. PubMed ID: 23023561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen Receptor Splice Variants Are Not Substrates of Nonsense-Mediated Decay.
    Ajiboye AS; Esopi D; Yegnasubramanian S; Denmeade SR
    Prostate; 2017 Jun; 77(8):829-837. PubMed ID: 28224650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand.
    Liu G; Sprenger C; Wu PJ; Sun S; Uo T; Haugk K; Epilepsia KS; Plymate S
    Oncotarget; 2015 Jan; 6(1):288-304. PubMed ID: 25481872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 20(S)-protopanaxadiol inhibition of progression and growth of castration-resistant prostate cancer.
    Cao B; Qi Y; Yang Y; Liu X; Xu D; Guo W; Zhan Y; Xiong Z; Zhang A; Wang AR; Fu X; Zhang H; Zhao L; Gu J; Dong Y
    PLoS One; 2014; 9(11):e111201. PubMed ID: 25375370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer.
    Sharp A; Coleman I; Yuan W; Sprenger C; Dolling D; Rodrigues DN; Russo JW; Figueiredo I; Bertan C; Seed G; Riisnaes R; Uo T; Neeb A; Welti J; Morrissey C; Carreira S; Luo J; Nelson PS; Balk SP; True LD; de Bono JS; Plymate SR
    J Clin Invest; 2019 Jan; 129(1):192-208. PubMed ID: 30334814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer.
    Marín-Aguilera M; Jiménez N; Reig Ò; Montalbo R; Verma AK; Castellano G; Mengual L; Victoria I; Pereira MV; Milà-Guasch M; García-Recio S; Benítez-Ribas D; Cabezón R; González A; Juan M; Prat A; Mellado B
    Cells; 2020 Jan; 9(1):. PubMed ID: 31947623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RNA helicase DDX39B and its paralog DDX39A regulate androgen receptor splice variant AR-V7 generation.
    Nakata D; Nakao S; Nakayama K; Araki S; Nakayama Y; Aparicio S; Hara T; Nakanishi A
    Biochem Biophys Res Commun; 2017 Jan; 483(1):271-276. PubMed ID: 28025139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.